Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Mira Pharmaceuticals, Inc.

NASDAQ: MIRA · Life Sciences · 5 alerts · CIK 1904286

Share price
$0.6310Close, Nov 16
Market cap
$26.5M
Shares outstanding
42.02MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Mira Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:09 PM ET 8-K
Clinical Trial Data

Mira Pharmaceuticals Clinical Trial Data

MIRA Pharmaceuticals announced new pharmacological findings for its investigational oral drug candidate MIRA-55, demonstrating high receptor selectivity for CB2 over opioid and COX receptors. The expanded screening showed a 500-fold separation from opioid receptor interactions, supporting its development as a differentiated non-opioid treatment for inflammatory pain. The company is currently advancing IND-enabling activities with a target submission date in the first half of 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.